Your browser doesn't support javascript.
loading
Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.
Vickers-Smith, Rachel; Sun, Jiangwen; Charnigo, Richard J; Lofwall, Michelle R; Walsh, Sharon L; Havens, Jennifer R.
Afiliação
  • Vickers-Smith R; University of Louisville School of Nursing, Louisville, KY 40202, USA; Department of Biostatistics, University of Kentucky College of Public Health, 111 Washington Avenue, Lexington, KY 40536, USA; Department of Epidemiology, University of Kentucky College of Public Health, 111 Washington Avenue, Le
  • Sun J; Department of Computer Science, Old Dominion University, Norfolk, VA 23529, USA.
  • Charnigo RJ; Department of Biostatistics, University of Kentucky College of Public Health, 111 Washington Avenue, Lexington, KY 40536, USA.
  • Lofwall MR; Center on Drug and Alcohol Research, Department of Behavioral Science, University of Kentucky College of Medicine, 845 Angliana Avenue, Lexington, KY 40508, USA.
  • Walsh SL; Center on Drug and Alcohol Research, Department of Behavioral Science, University of Kentucky College of Medicine, 845 Angliana Avenue, Lexington, KY 40508, USA; Department of Pharmaceutical Sciences, University of Kentucky College of Pharmacy, 789 South Limestone, Lexington, KY 40508, USA.
  • Havens JR; Department of Epidemiology, University of Kentucky College of Public Health, 111 Washington Avenue, Lexington, KY 40536, USA; Center on Drug and Alcohol Research, Department of Behavioral Science, University of Kentucky College of Medicine, 845 Angliana Avenue, Lexington, KY 40508, USA.
Drug Alcohol Depend ; 206: 107709, 2020 01 01.
Article em En | MEDLINE | ID: mdl-31732295

Texto completo: 1 Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Sistemas de Notificação de Reações Adversas a Medicamentos / Transtornos Relacionados ao Uso de Substâncias / Farmacovigilância / Gabapentina Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Sistemas de Notificação de Reações Adversas a Medicamentos / Transtornos Relacionados ao Uso de Substâncias / Farmacovigilância / Gabapentina Idioma: En Ano de publicação: 2020 Tipo de documento: Article